Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3614_Библиотеки_им_академика_М_И_Перельмана
.pdf
SECTION 1 Pathophysiology and investigation ofcoronary artery disease48
https://t.me/medicina_free
with known or suspected coronary artery disease:a systematic
review and meta- analysis. J Am Coll Cardiol. 2013;62(9):826– 38.
3. Gargiulo P, Dellegrottaglie S, Bruzzese D, Savarese G, Scala O,
Ruggiero D, etal. e prognostic value of normal stress cardiac
magnetic resonance in patients with known or suspected
coronary artery disease:a meta- analysis. Circ Cardiovasc
Imaging. 2013;6(4):574– 82.
4. Manka R, Jahnke C, Kozerke S, Vitanis V, Crelier G, Gebker
R, etal. Dynamic 3- dimensional stress cardiac magnetic
resonance perfusion imaging:detection of coronary artery
disease and volumetry of myocardial hypoenhancement
before and aer coronary stenting. J Am Coll Cardiol.
2011;57(4):437– 44.
5. Manka R, Wissmann L, Gebker R, Jogiya R, Motwani M,
Frick M, etal. Multicenter evaluation of dynamic threedimensional magnetic resonance myocardial perfusion
imaging for the detection of coronary artery disease defined
by fractional flow reserve. Circ Cardiovasc Imaging.
2015;8(5):e003061.
6. Bettencourt N, Ferreira N, Chiribiri A, Schuster A, Sampaio F,
Santos L, etal. Additive value of magnetic resonance coronary
angiography in a comprehensive cardiac magnetic resonance
stress- rest protocol for detection of functionally signicant
coronary artery disease:a pilot study. Circ Cardiovasc Imaging.
2013;6(5):730– 8.
7. Gotschy A, Wissmann L, Goolaub DS, Niemann M, Hamada
S, Kozerke S, etal. First fusion and combined evaluation of 3DCMR perfusion with 3D- MR coronary angiography. Int J Cardiol.
2016;202:62– 3.
8. Schwitter J, Wacker CM, van Rossum AC, Lombardi M, Al- Saadi
N, Ahlstrom H, etal. MR- IMPACT:comparison of perfusioncardiac magnetic resonance with single- photon emission
computed tomography for the detection of coronary artery
disease in a multicentre, multivendor, randomized trial. Eur
Heart J. 2008;29(4):480– 9.
9. Klein C, Nagel E, Gebker R, Kelle S, Schnackenburg B, Graf
K, etal. Magnetic resonance adenosine perfusion imaging
in patients aer coronary artery bypass gra surgery. JACC
Cardiovasc Imaging. 2009;2(4):437– 45.
10. Greenwood JP, Maredia N, Younger JF, Brown JM, Nixon J,
Everett CC, etal. Cardiovascular magnetic resonance and
single- photon emission computed tomography for diagnosis of
coronary heart disease (CE- MARC):a prospective trial. Lancet.
2012;379(9814):453– 60.
11. Nagel E, Lehmkuhl HB, Bocksch W, Klein C, Vogel U, Frantz E,
etal. Noninvasive diagnosis of ischemia- induced wall motion
abnormalities with the use of high- dose dobutamine stress
MRI:comparison with dobutamine stress echocardiography.
Circulation. 1999;99(6):763– 70.
12. Manka R, Jahnke C, Gebker R, Schnackenburg B, Paetsch I.
Head- to- head comparison of rst- pass MR perfusion imaging
during adenosine and high- dose dobutamine/ atropine stress. Int
J Cardiovasc Imaging. 2011;27(7):995– 1002.
13. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O,
etal. e use of contrast- enhanced magnetic resonance imaging
to identify reversible myocardial dysfunction. N Engl J Med.
2000;343(20):1445– 53.
14. Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M,
Parker M, etal. Contrast- enhanced MRI and routine single
photon emission computed tomography (SPECT) perfusion
imaging for detection of subendocardial myocardial infarcts:an
imaging study. Lancet. 2003;361(9355):374– 9.
5.4 Cardiac computedtomography
Steve L. Liao
Introduction
Rapid technological advances have allowed for the application of
computed tomography (CT) imaging for the evaluation of the heart.
Cardiac CT scanning is now a standard method to investigate the
anatomical structure of the heart and most commonly, the coronary
vasculature, given the prevalence of coronary artery disease (CAD)
and its associated morbidity and mortality. Due to the heart’s constant motion and the relatively small luminal diameters of the coronary arteries, scanning the heart and coronaries by CT presents
unique challenges for image acquisition normally not encountered
when imaging other anatomical areas.
Background ofcardiac computedtomography
A CT scanner acquires cross- sectional images axially, either in a
continuous fashion in the case of a retrospectively gated scan or in
a step- and- shoot fashion in the case of a prospectively gated scan.
Gating of the scan via the patient’s electrocardiogram is crucial and
unique to cardiac CT, permitting the images to be obtained during
cardiac diastole, when the heart is most still. Other techniques commonly used to optimize image quality include a breath- hold during
imaging acquisition and the administration of sublingual nitroglycerine and beta blockers prior to the scan. Employing these techniques improves image quality and reduces imaging artifacts most
commonly attributed to motion.
Improvements in CT scanner technology have resulted in incremental improvements in temporal, spatial, and contrast resolution
facilitating a more accurate interrogation of the coronary lumen
with a concomitant reduction in the overall administered radiation
dose. Driven by increases in the size and number of detectors used in
CT scanning, better imaging resolution has progressively improved
the diagnostic accuracy of CT in cardiac imaging.
Clinical use incardiology
Clinical use of cardiac CT scanning has focused primarily on the
diagnosis of CAD and can take the form of either a non- contrast
study in the case of a coronary artery calcium (CAC) score or an
intravenous contrast study in the case of a coronary CT angiogram
(CCTA). Other uses of cardiac CT include preprocedural imaging of
the le atrium prior to atrial brillation ablation and of the aorta and
vasculature prior to transcatheter aortic valve replacement. Cardiac
CT can also be helpful in the evaluation of coronary anomalies and
in structural heart disease by assessing cardiac size and function
when retrospective gating is utilized.
CACscore
Coronary artery calcication develops as part of the pathogenesis of
coronary atherosclerosis and is absent in normal vessel walls. e

5.4 Cardiac computedtomography 49
https://t.me/medicina_free
Fig.5.4.1 Multiplanar reconstructions of a normal left main and left anterior descending coronary artery (top red arrow) and of the right coronary
artery (bottom yellow arrow).
CAC score is obtained via a non- contrast CT scan or by electron
beam CT. e Multi- Ethnic Study of Atherosclerosis (MESA) investigated the relationship between coronary calcication and future
coronary events in four major ethnic groups and found that the CAC
score predicted the incidence of heart disease, providing predictive
information beyond that obtained from the standard Framingham
risk factors. ere has been debate about the appropriate clinical
application for the CAC score, despite its predictive value, given the
lack of prospective data showing improvement in outcomes with
therapy.
CCTA
CCTA provides high- quality diagnostic images of the coronary
vasculature non- invasively (Fig. 5.4.1) and can help characterize
the type, location, and extent of plaque within the coronary artery
(Fig. 5.4.2). Indeed, numerous studies have demonstrated the
ability of this modality to accurately diagnose obstructive CAD.
Additionally, each subsequent generation of scanner improves on
the diagnostic quality and accuracy achieved by the previous generation., e pooled sensitivity and specicity has been reported
to be 98% and 91%, respectively. CCTA also provides an accurate
means to non- invasively assess the patency of coronary arty bypass
gras. As gras usually experience less motion and, in the case of
saphenous venous gras, can be larger in calibre, a high sensitivity
and specicity are observed with the use of CCTA for gra interrogation.– Importantly, the extent and the severity of CAD as detected by CCTA have been shown to have prognostic signicance.
A natural application of this technology can be found in assessing
patients presenting to the emergency department with a chest pain
syndrome. e use of CCTA in the emergency department was
shown to improve the eciency of clinical decision- making compared to standard evaluation in this setting but had no eect on
overall cost of care. Additionally, CCTA eectively triaged those
patients with a low- to- intermediate clinical risk of obstructive CAD
to a safe and expedited discharge. Amore recent and larger randomized but open trial showed that CCTA was able to accurately
diagnose obstructive CAD and resulted in a reduction in the need
for stress testing. is study showed an increased usage of cardiac
catheterization to target interventions of obstructive CAD detected
by CCTA.

SECTION 1 Pathophysiology and investigation ofcoronary artery disease50
https://t.me/medicina_free
Fig.5.4.2 Multiplanar reconstructions of a left anterior descending coronary artery with significant obstructive disease consisting of calcified and
non- calcified plaques (top red arrow) and of the right coronary artery with obstructive disease consisting primarily of non- calcified disease (bottom
yellow arrow).
A large randomized trial investigated the use of CCTA in symptomatic patients without diagnosed CAD, in a non- urgent setting. is study compared an initial approach using CCTA against
standard functional testing (exercise electrocardiography, nuclear
stress testing, or stress echocardiography). CCTA did not improve
are still ongoing, recent randomized trials failed to show superiority of CCTA over functional testing, suggesting that even in
this age of impressive technological advances, a physician’s clinical judgement in selecting the appropriate test for a specic pa-
tient remains vital.
clinical outcomes compared with functional testing over a period
of approximately 2years, with the caveat that the overall event rates
were low, 3.1%. Interestingly, in contrast to the previous study, this
study showed that CCTA led to fewer catheterizations than did
functional testing.
e future of cardiac CT is bright. Of the dierent applications and techniques that are being developed, the calculation
of fractional ow reserve from CCTA is showing itself to be a
promising technique. Its use in conjunction with CCTA is being
studied as a replacement for diagnostic cardiac catheterization in
patients referred for coronary artery bypass graing. Cardiac
CT has evolved rapidly and has demonstrated the ability to accurately diagnose CAD and help with prognosticating future events.
While studies comparing dierent CAD assessment modalities
REFERENCES
1. Mahesh M, Cody DD. Physics of cardiac imaging with multiplerow detector CT. RadioGraphics. 2007;27(5):1495– 509.
2. Kalisz K, Buethe J, Saboo SS, Abbara S, Halliburton S, Rajiah P.
Artifacts at cardiac CT:physics and solutions. RadioGraphics.
2016;36(7):2064– 83.
3. Vanhoenacker PK, Heijenbrok- Kal MH, Van Heste R, Decramer
I, Van Hoe LR, Wijns W, etal. Diagnostic performance of
multidetector CT angiography for assessment of coronary artery
disease:meta- analysis. Radiology. 2007;244(2):419– 28.
4. Greenland P, Bonow RO, Brundage BH, Budo MJ, Eisenberg MJ,
Grundy SM, etal. ACCF/ AHA 2007 clinical expert consensus

5.4 Cardiac computedtomography 51
https://t.me/medicina_free
document on coronary artery calcium scoring by computed
tomography in global cardiovascular risk assessment and in
evaluation of patients with chest pain:a report of the American
College of Cardiology Foundation Clinical Expert Consensus Task
Force (ACCF/ AHA Writing Committee to Update the 2000 expert
consensus document on electron beam computed tomography)
developed in collaboration with the Society of Atherosclerosis
Imaging and Prevention and the Society of Cardiovascular
Computed Tomography. J Am Coll Cardiol. 2007;49(3):378– 402.
5. Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR,
etal. Coronary calcium as a predictor of coronary events in four
racial or ethnic groups. N Engl J Med. 2008;358(13):1336– 45.
6. Redberg RF. What is the prognostic value of a zero calcium score?
J Am Coll Cardiol. 2010;55(7):635– 6.
7. Garcia MJ, Lessick J, Homann MH, CATSCAN Study
Investigators. Accuracy of 16- row multidetector computed
tomography for the assessment of coronary artery stenosis.
JAMA. 2006;296(4):403– 11.
8. Miller JM, Rochitte CE, Dewey M, Arbab- Zadeh A, Niinuma H,
Gottlieb I, etal. Diagnostic performance of coronary angiography
by 64- row CT. N Engl J Med. 2008;359(22):2324– 36.
9. Menke J, Unterberg- Buchwald C, Staab W, Sohns JM, Seif
Amir Hosseini A, Schwarz A. Head- to- head comparison of
prospectively triggered vs retrospectively gated coronary
computed tomography angiography:meta- analysis of diagnostic
accuracy, image quality, and radiation dose. Am Heart J.
2013;165(2):154– 63.e3.
10. Nieman K, Pattynama PM, Rensing BJ, Van Geuns RJ, De
Feyter PJ. Evaluation of patients aer coronary artery bypass
surgery:CT angiographic assessment of gras and coronary
arteries. Radiology. 2003;229(3):749– 56.
11. Ropers D, Pohle FK, Kuettner A, Pederer T, Anders K, Daniel
WG, etal. Diagnostic accuracy of noninvasive coronary
angiography in patients aer bypass surgery using 64- slice spiral
computed tomography with 330- ms gantry rotation. Circulation.
2006;114(22):2334– 41.
12. Gramer BM, Diez Martinez P, Chin AS, Sylvestre MP, Larrivée
S, Stevens LM, etal. 256- Slice CT angiographic evaluation of
coronary artery bypass gras:eect of heart rate, heart rate
variability and Z- axis location on image quality. PLoS One.
2014;9(3):e91861.
13. Cho I, Chang HJ, Sung JM, Pencina MJ, Lin FY, Dunning AM,
etal. Coronary computed tomographic angiography and risk
of all- cause mortality and nonfatal myocardial infarction in
subjects without chest pain syndrome from the CONFIRM
Registry (coronary CT angiography evaluation for clinical
outcomes:an International Multicenter Registry). Circulation.
2012;126(3):304– 13.
14. Homann U, Truong QA, Schoenfeld DA, Chou ET, Woodard
PK, Nagurney JT, etal. Coronary CT angiography versus
standard evaluation in acute chest pain. N Engl J Med.
2012;367(4):299– 308.
15. Litt HI, Gatsonis C, Snyder B, Singh H, Miller CD, Entrikin
DW, etal. CT angiography for safe discharge of patients
with possible acute coronary syndromes. N Engl J Med.
2012;366(15):1393– 403.
16. SCOT- HEART investigators. CT coronary angiography in
patients with suspected angina due to coronary heart disease
(SCOT- Heart):an open- label, parallel- group, multicentre trial.
Lancet. 2015;385(9985):2383– 91.
17. Douglas PS, Homann U, Patel MR, Mark DB, Al- Khalidi
HR, Cavanaugh B, etal. Outcomes of anatomical versus
functional testing for coronary artery disease. N Engl J Med.
2015;372(14):1291– 300.
18. Min JK, Leipsic J, Pencina MJ, Berman DS, Koo BK,
van Mieghem C, etal. Diagnostic accuracy of fractional
ow reserve from anatomic CT angiography. JAMA.
2012;308(12):1237– 45.
19. Modolo R, Collet C, Onuma Y, Serruys PW. SYNTAX II and
SYNTAX III trials:what is the take home message for surgeons?
Ann Cardiothorac Surg. 2018;7(4):470– 82.
20. Stillman AE, Gatsonis C, Lima JA, Black WC, Cormack J,
Gareen I, etal. Rationale and design of the Randomized
Evaluation of patients with Stable angina Comparing Utilization
of noninvasive Examinations (RESCUE) trial. Am Heart J.
2016;179: 19– 28.

https://t.me/medicina_free

https://t.me/medicina_free
6
Ischaemia, hibernation, andviability
Roberto Ferrari
It was dogma for many years that if myocardial ischaemia persists
for more than 30 minutes, necrosis will develop, resulting in myocardial infarction. e unavoidable extrapolation of that dogma
suggested that chronic ischaemia, in reality, cannot exist, as it will
inevitably evolve into structural changes (i.e. irreversible damage).
ese tenets were overturned in the early 1980s when Rahimtoola
reviewed the results of coronary bypass surgery trials and identied
patients with coronary artery disease and chronic le ventricular
dysfunction persisting for months and even years that improved
aer revascularization. e rapid amelioration of myocardial function obtained by revascularization ruled out the hypothesis that the
reduced function was due to histological modication of the myocardium and le the entire scientic community with the dilemma
to explain and recognize hibernating myocardium.
Hibernation immediately attracted the attention of basic scientists
and several experimental models and studies were quickly undertaken. us, Ross and Heusch described hibernating myocardium
as the result of a proportionate reduction in blood supply and contractile function, the so called perfusion– contraction matching. is
idea gained immediate consensus, both in the acute experimental
models and in some clinical settings (i.e. short- term hibernation),
while a chronic perfusion– contraction matching (i.e. chronic hibernation) resulted in a long- lasting and, to some extent, semantic
controversy:reduced versus preserved baseline ow in hibernating
myocardium.– How could hibernation, which is an expression of
ischaemia, exist in the presence of normal ow? Of course all depends on the denition of ischaemia and, amazingly, as late as 1994
there was no clear accepted denition of ischaemia. e majority of
studies reported reduced resting ow in the hibernating segments,
but others found no reduction. As a result, the idea that hibernation is consequent to repetitive episodes of post- ischaemic stunning
developed. Even this hypothesis seems unrealistic, as stunning and
hibernation are distinct entities with respect to their origin and natural history. Stunning occurs on reperfusion, hibernation needs reperfusion to be established! Another mystery relates to the intrinsic
cause and consequences of the downregulation of contractility of
hibernating myocardium, which has been considered either ‘smart’
or ‘selsh’. ‘Smart’ because it is capable of adapting to unfavourable
circumstances by appropriately downregulating its biochemical and
physiological activity as an act of self- preservation. By contrast, for
the whole body or for the patient, this mechanism is unfavourable
because it is aimed at preserving myocyte integrity at the expense of
contraction and hence cardiac output. An interesting hypothesis to
explain the intrinsic mechanism of the downregulation in contraction relates to intracellular acidosis, which is known to compete and
freeze calcium movements through all cell membranes. It has been
suggested that the acute ischaemic insult (either angina or an acute
coronary syndrome) that always precedes hibernation causes a drop
of tissue pH which, in turn, reduces contraction and therefore energy
need. ereaer, some collateral ow likely develops, though is not
enough to restore normal pH, but enough to provide the mitochondria of quiescent non- contracting myocytes with the oxygen necessary to produce enough energy to maintain viability. Reperfusion
at this stage restores normal pH and a prompt recovery of function.
ese series of events, summarized in Fig. 6.1, have been shown in
isolated and perfused rabbits hearts and conrmed in larger animals., It is likely that in the human ischaemic tissue there is a
continuum sequence of no- and low- ow ischaemia causing a sort
of preconditioning with a consequent metabolic adaptation during
the collateral- mediated low- ow phase. Such a sequence of metabolic adaptation has been shown in patients with hibernating myocardium subjected to surgical revascularization.
Whatever the mechanism, what matters is the separation of
‘hibernating’ and ‘stunned’ (viable) from infarcted (dead) myocardium and the identication of these entities has become a major
clinical goal. In the early days of hibernation, a variety of techniques
became available to detect viability and these can be broadly divided into two groups:(1) radioactive tracers of perfusion that depend on the integrity of the sarcolemma for myocardial uptake and
retention (i.e. thallium or rubidium scintigraphy) or preservation of
myocardial metabolism (i.e. positron emission tomography (PET))
and (2)characterization of the hypokinetic segments (i.e. wall thickness) with stimulants of inotropic reserve (i.e. post- extrasystolic potentiation and low- dose dobutamine stress echocardiography). e
most recent technological developments in cardiovascular imaging
have expanded the possibility to detect viability. PET, which assesses
myocardial function, perfusion, and metabolism, is highly recommended for diagnosis of hibernation. Viable tissue metabolizes
both free fatty acids and glucose, while dysfunctional myocytes depend on anaerobic glucose metabolism. By combining perfusion

SECTION 1 Pathophysiology and investigation ofcoronary artery disease54
Ischaemic insult
https://t.me/medicina_free
Acidosis
↑ Pi
Akinetic
Reduction of oxygen
demand (mitochondrial oxidation)
Residual collateral flow
enough to support the
reduced mitochondrial
oxidation but not enough
to restore normal pH and Pi
Hibernation
Fig.6.1 Schematic representation of the role of akinesia in the
development of hibernation. Pi, inorganic phosphate.
tracer (usually nitrogen- 13 labelled ammonia or rubidium- 82) with
uorodeoxyglucose, a glucose analogue, PET distinguishes normal
(normal function, perfusion, and metabolism) from stunned (dysfunctional but with normal perfusion and metabolism) and hibernating myocardium (diminished function and perfusion but normal
free fatty acid metabolism). Cardiac magnetic resonance (CMR) also
detects myocardial viability by means of delayed contrast enhancement or of dobutamine CMR. Delayed contrast- enhanced CMR
assesses anatomical myocardial tissue as hibernating as opposed to
infarcted myocardium when it has a normal distribution volume of
contrast medium and does not demonstrate hyperenhancement.
Similar to echocardiography, dobutamine CMR visualizes, with
high spatial resolution and regional denition, wall motion and systolic wall thickening. Cardiac computed tomography at present is
not recommended to detect hibernation because of the radiation exposure and absence of studies proving its usefulness. In addition,
recent soware has made it possible to merge CMR with nuclear
imaging (single- photon emission computed tomography/ PET)
datasets and most likely this new hybrid imaging will constitute the
gold standard for detection of hibernation. Of course, all of these
techniques have intrinsic pros and cons, require several degrees of
knowledge, and have dierent complexity and costs. Nonetheless,
from a pragmatic point of view, those testing the contractile reserve
in addition to viability provide critically important information on
the likelihood of recovery aer reperfusion/ revascularization.
It is relevant to underline that all of the currently employed diagnostic techniques are just markers of myocardial viability. e only
appropriate standard is recovery of function upon revascularization
and, eventually, reduction in symptoms and improvement of survival., Data related to the prognostic value of revascularization
of hibernating myocardium are scanty. Two studies suggest a lower
event rate in patients with areas of viable myocardium undergoing
revascularization in comparison with those with similar areas of
hibernation without revascularization., Another still grey area
relates to the extension of viable myocardium required to be present to provide clinical benets once reperfused. Abetter outcome
aer surgical revascularization occurs mainly for patients with severely impaired ejection fraction. Ideally, the mass of myocardial
viability should be (at least) more than 20% of the le ventricle to
make the revascularization and its intrinsic risk worthwhile. e
indication for revascularization is not limited to the presence of
angina pectoris or inducible ischaemia, but also extends to those patients with signs of heart failure, sometimes on the waiting list for
transplantation. Indeed, a diagnosis of hibernation will drive clinical decision- making towards revascularization as an alternative to
transplantation for patients with severe ischaemic cardiomyopathy.
Another unknown issue relating to hibernation is its actual
prevalence. One thing is clear:not all hearts that are subjected to
a restriction of coronary ow are able to survive and recover. Not
surprisingly, there are few data on the incidence of hibernating myocardium. is is primarily due to the fact that the concept is relatively new, counterintuitive, not unanimously accepted, and there is
no standard simple procedure for recognition of dysfunctional but
still viable myocardium. Despite all these caveats, it appears that hibernation may be more common in unstable rather than stable angina. e incidence in non Q- wave myocardial infarction has been
suggested to be 20%. About 15% of patients referred to cardiac
transplantation have hibernating myocardium. ough available
studies suggest that hibernation is a rare phenomenon, it is more
frequent than originally thought and it is easier to miss than to nd
it. e problem, once again, relies on the diculty in distinguishing
between wall motion abnormalities due to real hibernation and
those due to non- transmural myocardial infarction.
e treatment of hibernating myocardium should be by reperfusion as no data exist about the ecacy of pharmacological treatment. eoretically, drugs that improve coronary ow and protect
ischaemic myocytes should be useful, but may carry a risk to trigger
arrhythmias. e knowledge that a large portion of dysfunctional
myocardium is viable rather than brotic and that is likely to recover upon reperfusion has shed a completely new light onto the
entire issue. Clinicians have long linked reduced systolic function
to mortality and symptomatic status. But today, a low ejection
fraction is no longer an absolute prognostic indicator of survival.
e mechanisms by which reperfusion is benecial are multiple.
Revascularization reduces the likelihood of new ischaemic episodes,
allows contractile recovery of the myocardium, which is potentially
viable, arrests any further deterioration in systolic function (or reduces remodelling), and prevents lethal arrhythmias, typical of nonrevascularized hibernating myocardium.
e original intuition of Rahitmoola in 1989 has radically
changed the current physiopathological concept of myocardial ischaemia and the treatment of some patients with coronary artery
disease. Myocardial hibernation, non- transmural infarction, and
normally functioning non- ischaemic myocardium probably all coexist in patients with chronic le ventricular function. e available
imaging techniques appear to be accurate markers for segments that
contain viable myocardium and should be used more frequently
to predict the success of revascularization. At present, the mechanisms leading to hibernation are unknown. We need to clarify
what the stimulus is and the signal transduction for hibernation
and to discover the precise metabolic adaptation and the cause of
downregulation of myocardial function, along with the roles of collateral ow and inammation. As Gerd Heusch stated, many more
questions must be answered before exploitation of the hibernation

6 Ischaemia, hibernation, andviability 55
https://t.me/medicina_free
paradigm is possible. Doubtless Rahitmoola was not aware that he
would raise so many questions when he described the results of his
observations. is is the goal of great scientists:to observe and report phenomena even when they go against current dogmas and
feed the scientic community with many questions.
11. Schulz R, Post H, Sakka S, Wallbridge DR, Heusch G.
Intraischemic preconditioning. Increased tolerance to sustained
low- ow ischemia by a brief episode of no- ow ischemia without
intermittent reperfusion. Circ Res. 1995;76(6):942– 50.
12. Heusch G, Post H, Michel MC, Kelm M, Schulz R. Endogenous
nitric oxide and myocardial adaptation to ischemia. Circ Res.
2000;87(2):146– 52.
Acknowledgement
13. Ceconi C, La Canna G, Aleri O, Cargnoni A, Coletti G, Curello
S, etal Revascularization of hibernating myocardium:rate of
metabolic and functional recovery and occurrence of oxidative
is work was supported by the Fondazione Anna Maria Sechi per
il Cuore.
stress. Eur Heart J. 2002;23(23):1877– 85.
14. Bonow RO, Maurer G, Lee KL, Holly TA, Binkley PF,
Desvigne- Nickens P, etal. Myocardial viability and survival
in ischemic le ventricular dysfunction. N Engl J Med.
REFERENCES
1. Rahimtoola SH. A perspective on the three large multicenter
randomized clinical trials of coronary bypass surgery for chronic
stable angina. Circulation. 1985;72(6 Pt 2, Suppl V):V123– 35.
2. Ross J Jr. Myocardial perfusion- contraction matching.
Implications for coronary heart disease and hibernation.
Circulation. 1991;83(3): 1076– 83.
3. Heusch G. Hibernating myocardium. Physiol Rev. 1998;78(4):
1055– 85.
4. Heusch G, Schulz R. Perfusion- contraction match and mismatch.
Basic Res Cardiol. 2001;96(1):1– 10.
5. Camici PG, Wijns W, Borgers M, De Silva R, Ferrari R,
Knuuti J, etal Pathophysiological mechanisms of chronic
reversible le ventricular dysfunction due to coronary
artery disease:hibernating myocardium. Circulation.
1997;96(9):3205– 14.
6. Schulz R, Post H, Neumann T, Gres P, Lüss H, Heusch G.
Progressive loss of perfusion- contraction matching during
sustained moderate ischemia in pigs. Am J Physiol Heart Circ
Physiol. 2001;280(5):H1945– 53.
7. Hearse DJ. Myocardial ischemia:can we agree a
denition for the 21st century? Cardiovasc Res.
1994;28(12):1737– 44:discussion 1745.
8. Shen YT, Vatner SF. Mechanism of impaired myocardial
function during progressive coronary stenosis in conscious
pigs:hibernation versus stunning. Circ Res. 1995;76(3):479– 88.
9. Ferrari R. e search for the hibernating myocardium— have we
reached the limit? Cardiovasc Drugs er. 1999;13(2):137– 43.
10. Ferrari R, Cargnoni A, Bernocchi P, Pasini E, Curello S, Ceconi C,
2011;364(17):1617– 25.
15. Hussain ST, Chiribiri A, Morton G, Bettencourt N, Schuster A,
Paul M, etal. Perfusion cardiovascular magnetic resonance and
fractional ow reserve in patients with angiographic multi- vessel
coronary artery disease. J Cardiovasc Magn Reson. 2016;18(1):44.
16. Pinto FJ. Myocardial viability:the search for a perfect method is
not over yet. Eur Heart J. 2000;21(13):1039– 40.
17. Armstrong WF. ’Hibernating’ myocardium:asleep or part dead? J
Am Coll Cardiol. 1996;28(2):530– 5.
18. Ferrari R, Ferrari F, Benigno M, Pepi P, Visioli O. Hibernating
myocardium:its pathophysiology and clinical role. Mol Cell
Biochem. 1998;186(1– 2):195– 9.
19. Eitzman D, Al- Aouar Z, Kanter HL, vom Dahl J, Kirsh M, Deeb
GM, etal. Clinical outcome of patients with advanced coronary
artery disease aer viability studies with positron emission
tomography. J Am Coll Cardiol. 1992;20(3):559– 65.
20. Di Carli MF, Davidson M, Little R, Khanna S, Mody FV, Brunken
RC, etal. Value of metabolic imaging with positron emission
tomography for evaluating prognosis in patients with coronary
artery disease and le ventricular dysfunction. Am J Cardiol.
1994;73(8):527– 33.
21. La Canna G, Aleri O, Giubbini R, Gargano M, Ferrari R,
Visioli O. Echocardiography during infusion of dobutamine for
identication of reversibly dysfunction in patients with chronic
coronary artery disease. J Am Coll Cardiol. 1994;23(3):617– 26.
22. Ferrari R, Ceconi C, Curello S, Benigno M, La Canna G,
Visioli O. Le ventricular dysfunction due to the new ischemic
outcomes: stunning and hibernation. J Cardiovasc Pharmacol.
1996;28(Suppl 1):S18– 26.
23. Rahimtoola SH. Hibernating myocardium:a brief article. Basic
Res Cardiol. 1995;90(1):38– 40.
ow ischaemia:a possible trigger for hibernation. Circulation.
1996;94(10):2587– 96.
24. Heusch G, Schulz R. Hibernating myocardium:new answers, still
more questions! Circ Res. 2002;91(10):863– 5.

https://t.me/medicina_free

https://t.me/medicina_free
7
Invasive investigation ofcoronary
arterydisease
7.1 Angiography
Normal angiographic anatomy ofthe left
and right coronaryarteries
Matthew I. Tomey
Normal angiographic anatomy of the native le and right cor-
Diagnostic coronary angiography:a briefhistory
‘As an aid to diagnosis in ischaemic heart- disease’, Lancet editorialists wrote in 1966, coronary angiography ‘seems at present to oer
little that cannot be more easily obtained by much simpler methods,
such as good history- taking and electrocardiography’. Since its serendipitous origins at the Cleveland Clinic laboratory of Dr F.Mason
Sones in 1958, selective coronary angiography has taken on central
importance in the diagnosis of coronary artery disease and characterization of coronary anatomy prior to coronary artery bypass gra
surgery. Performance has become simpler and safer, evolving from
a brachial artery cut- down approach with sti, large- calibre multipurpose catheters to percutaneous femoral, radial, and now ulnar
approaches with soer, lower- prole catheters specially designed to
atraumatically engage the coronary ostia.
Procedureoverview
First, arterial access is obtained by the modied Seldinger technique, most commonly via the femoral or radial artery. In a
retrograde fashion, a coronary catheter is then advanced over a
guidewire through the percutaneous introducer sheath to the ascending aorta. ere, aer de- airing the catheter, the catheter tip
is engaged in the ostium of the right or le coronary artery under
uoroscopic guidance. Radiocontrast medium is selectively injected
into the coronary artery, with motion picture recording of injections
(‘cineangiography’) in multiple views. e process is repeated for
the other coronary artery. is can be accomplished with a single
multipurpose catheter or with specialized le and right catheters.
Coronary angiography is oen paired with insertion of a catheter
into the le ventricle to record pressures, with or without contrast
ventriculography (‘le heart catheterization’). When there has been
previous coronary artery bypass gra surgery, gra angiography can
be performed in a similar fashion and in the same setting.
onary arteries is depicted in Fig. 7.1.1. Due to compression of
the three- dimensional anatomy of the coronary vasculature into
a two- dimensional lm, single views are subject to overlap and
foreshortening. Proper coronary angiography requires multiple
views of each coronary artery to permit complete visualization.
Angiographic diagnosis and classification
ofcoronarylesions
Coronary angiography illustrates not the artery itself, but rather
the opacication of its lumen. Diagnosis, grading, and classication of coronary lesions, accordingly, derive from deviations in
the expected smooth, tapering, branching contour of the coronary
lumen.
Coronary lesions appear as a reduction in luminal diameter relative to the reference vessel diameter. Common categories for visually estimated diameter stenosis include less than 30%, 30– 50%,
50– 60%, 60– 70%, 70– 80%, 80– 90%, 90– 95%, 99% (subtotal occlusion, with slow ow), and 100% (total occlusion, with no ow), with
greater than 70% stenosis typically considered angiographically signicant (or >50% for the le main coronary artery). Stenosis of less
than 50% is typically considered ‘non- obstructive’, whereas intermediate stenosis of 50– 70% may require additional testing to determine functional signicance. Whereas some lesions are concentric,
others are eccentric, appearing mild or absent in orthogonal views;
accordingly, the assigned grade of a given stenosis is taken from the
view in which it appears most severe.
Coronary angiography is eective for demonstrating and grading
not only stenosis severity but also complex lesion features which
increase diculty and risk of percutaneous coronary intervention
(PCI). Examples include calcication, bifurcation morphology,
and chronic total occlusion (Fig. 7.1.2). e Synergy Between PCI
With TAXUS and Cardiac Surgery (SYNTAX) score aggregates
angiographic data on the extent and complexity of coronary artery
disease into a single semiquantitative score useful in triage to PCI
versus coronary artery bypass graing.
Соседние файлы в папке Библиотека им академика М.И. Перельмана
